NTS-WBRT in Brain Metastases

Summary

This research is being done to assess the quality of life and symptom burden in participants who receive (normal tissue sparing whole brain radiation therapy (NTS-WBRT). This research study involves: * NTS-WBRT (normal tissue sparing whole brain radiation therapy) * Memantine standard of care drug

Timeline

Start

2022-02-08

Primary completion

2027-12-31

Completion

2027-12-31

Drugs

Indications